- Home
- MRVI vs CLPT Comparison
MRVI vs CLPT Comparison
Compare MRVI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- CLPT
- Stock Information
- Founded
- MRVI 2014
- CLPT 1998
- Country
- MRVI United States
- CLPT United States
- Employees
- MRVI N/A
- CLPT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- MRVI Health Care
- CLPT Health Care
- Exchange
- MRVI Nasdaq
- CLPT Nasdaq
- Market Cap
- MRVI 371.8M
- CLPT 317.4M
- IPO Year
- MRVI 2020
- CLPT N/A
- Fundamental
- Price
- MRVI $2.42
- CLPT $10.49
- Analyst Decision
- MRVI Hold
- CLPT Strong Buy
- Analyst Count
- MRVI 10
- CLPT 3
- Target Price
- MRVI $5.84
- CLPT $27.67
- AVG Volume (30 Days)
- MRVI 1.5M
- CLPT 375.5K
- Earning Date
- MRVI 08-11-2025
- CLPT 08-12-2025
- Dividend Yield
- MRVI N/A
- CLPT N/A
- EPS Growth
- MRVI N/A
- CLPT N/A
- EPS
- MRVI N/A
- CLPT N/A
- Revenue
- MRVI $219,830,000.00
- CLPT $33,593,000.00
- Revenue This Year
- MRVI N/A
- CLPT $22.34
- Revenue Next Year
- MRVI $7.23
- CLPT $25.50
- P/E Ratio
- MRVI N/A
- CLPT N/A
- Revenue Growth
- MRVI N/A
- CLPT 19.68
- 52 Week Low
- MRVI $1.67
- CLPT $9.76
- 52 Week High
- MRVI $9.60
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- CLPT 44.46
- Support Level
- MRVI $2.28
- CLPT $10.42
- Resistance Level
- MRVI $2.47
- CLPT $10.88
- Average True Range (ATR)
- MRVI 0.14
- CLPT 0.52
- MACD
- MRVI -0.01
- CLPT -0.01
- Stochastic Oscillator
- MRVI 27.45
- CLPT 22.75
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.